Macrophage inhibitory cytokine-1 (MIC-1/GDF15), CCAAT/enhancer binding protein delta (CEBPD) and neuroinflammtion

点击翻译按钮获取中文摘要

I will develop new therapies for multiple sclerosis and spinal cord injury. I will also evaluate diagnostic and therapeutic uses for macrophage inhibitory cytokine-1 (MIC-1/GDF15) that was discovered in Australia. I will confirm its use in screening for bowel cancer. Also, I will look at using it in the indigenous and wider Australian community to improve health and close the gap in life expectancy. Finally, I will conduct trials of MIC-1/GDF15 therapy of obesity and inflammation.